Rotation grant: Targeting MEF2D-dependent transcription to treat sepsis-induced acute heart failure
| Institution | Universität Heidelberg |
|---|---|
| Project leader | Richard Schell |
| Site | Heidelberg/Mannheim |
| Project type | Exzellenzprogramm |
| Funding | € 108.600,00 |
| Begin | 01.12.2020 |
| End | 31.10.2023 |
Förderkennzeichen
81X3500126
Projektnummer
1239